Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTNEP: Botox for Peripheral Neuropathic Pain
NCT01251211Phase 4Completed
- Sponsor
- Hôpital Ambroise-Paré
- Start
- Oct 2010
- Primary completion
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in Peripheral neuropathic pain comparing Botulinum toxin type A with Placebo (2 arms). Primary endpoint: Average pain intensity on numerical scales in a self diary at 6 months. Started Oct 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT01251211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01251211.